Polydatin supplementation ameliorates diet-induced development of insulin resistance and hepatic steatosis in rats

被引:67
作者
Zhang, Qi [1 ]
Tan, Yingying [1 ]
Zhang, Nan [1 ]
Yao, Fanrong [2 ]
机构
[1] Shaanxi Univ Chinese Med, Basic Med Coll, Dept Physiol, Xianyang 712046, Shaanxi, Peoples R China
[2] E Carolina Univ, Brody Sch Med, Dept Pharmacol & Toxicol, Greenville, NC 27834 USA
基金
中国国家自然科学基金;
关键词
polydatin; fatty liver; insulin resistance; adipokine; insulin receptor substrate; leptin; hepatic steatosis; NONALCOHOLIC FATTY LIVER; LIPID-METABOLISM; POLYGONUM-CUSPIDATUM; DISEASE; IRS-2; MICE; STEATOHEPATITIS; RECEPTOR; GLUCOSE; PHOSPHORYLATION;
D O I
10.3892/mmr.2014.2708
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
The pathophysiology of non-alcoholic fatty liver disease remains to be elucidated, and the currently available treatments are not entirely effective. Polydatin, a stilbenoid compound derived from the rhizome of Polygonum cuspidatum, has previously been demonstrated to possess hepatoprotective effects. The present study aimed to determine the effects of polydatin supplementation on hepatic fat accumulation and injury in rats fed a high-fat diet. In addition, the mechanisms underlying the protective effects of polydatin were examined. Male Sprague Dawley rats were randomly divided into four groups and received one of four treatment regimes for 12 weeks: Control diet, control diet supplemented with polydatin, high-fat diet, or high-fat diet supplemented with polydatin. Polydatin was supplemented in the drinking water at a concentration of 0.3% (wt/vol). The results of the present study showed that long-term high-fat feeding resulted in fatty liver in rats, which was manifested by excessive hepatic neutral fat accumulation and elevated plasma alanine aminotransferase and aspartate aminotransferase levels. Polydatin supplementation alleviated the hepatic pathological changes, and attenuated the insulin resistance, as shown by an improved homeostasis model assessment of basal insulin resistance values and a glucose tolerance test. Polydatin supplementation also corrected abnormal leptin and adiponectin levels. Specifically, polydatin supplementation enhanced insulin sensitivity in the liver, as shown by improved insulin receptor substrate 2 expression levels and Akt phosphorylation in the rat liver, following high-fat diet feeding. The results of the present study suggest that polydatin protects rats against high-fat feeding-induced insulin resistance and hepatic steatosis. Polydatin may be an effective hepatoprotective agent and a potential candidate for the prevention of fatty liver disease and insulin resistance.
引用
收藏
页码:603 / 610
页数:8
相关论文
共 41 条
[1]
Nonalcoholic fatty liver disease [J].
Brunt, Elizabeth M. ;
Wong, Vincent W. -S. ;
Nobili, Valerio ;
Day, Christopher P. ;
Sookoian, Silvia ;
Maher, Jacquelyn J. ;
Bugianesi, Elisabetta ;
Sirlin, Claude B. ;
Neuschwander-Tetri, BrentA. ;
Rinella, Mary E. .
NATURE REVIEWS DISEASE PRIMERS, 2015, 1
[2]
Phosphorylation of IRS proteins, insulin action, and insulin resistance [J].
Boura-Halfon, Sigalit ;
Zick, Yehiel .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2009, 296 (04) :E581-E591
[3]
Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x
[4]
Insulin resistance: A metabolic pathway to chronic liver disease [J].
Bugianesi, E ;
McCullough, AJ ;
Marchesini, G .
HEPATOLOGY, 2005, 42 (05) :987-1000
[5]
The phosphoinositide 3-kinase pathway [J].
Cantley, LC .
SCIENCE, 2002, 296 (5573) :1655-1657
[6]
Nonalcoholic fatty liver disease [J].
Clark, JM ;
Brancati, FL ;
Diehl, AM .
GASTROENTEROLOGY, 2002, 122 (06) :1649-1657
[7]
Lipid-lowering effects of polydatin from Polygonum cuspidatum in hyperlipidemic hamsters [J].
Du, Jian ;
Sun, Lian-Na ;
Xing, Wei-Wei ;
Huang, Bao-Kang ;
Jia, Min ;
Wu, Jin-Zhong ;
Zhang, Hong ;
Qin, Lu-Ping .
PHYTOMEDICINE, 2009, 16 (6-7) :652-658
[8]
Clinical features and natural history of nonalcoholic steatosis syndromes [J].
Falck-Ytter, Y ;
Younossi, ZM ;
Marchesini, G ;
McCullough, AJ .
SEMINARS IN LIVER DISEASE, 2001, 21 (01) :17-26
[9]
Nonalcoholic fatty liver disease: From steatosis to cirrhosis [J].
Farrell, GC ;
Larter, CZ .
HEPATOLOGY, 2006, 43 (02) :S99-S112
[10]
FOLCH J, 1957, J BIOL CHEM, V226, P497